TL13-110 is a negative control for TL13-112 ( HY-123919 ) and a potent ALK inhibitor with an IC 50 of 0.34 nM. TL13-110 does not degrade ALK in cells.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Anaplastic lymphoma kinase (ALK)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.